Literature DB >> 10531420

The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.

A R White1, G Multhaup, F Maher, S Bellingham, J Camakaris, H Zheng, A I Bush, K Beyreuther, C L Masters, R Cappai.   

Abstract

The amyloid precursor protein (APP) of Alzheimer's disease can reduce copper (II) to copper (I) in a cell-free system potentially leading to increased oxidative stress in neurons. We used neuronal cultures derived from APP knock-out (APP(-/-)) and wild-type (WT) mice to examine the role of APP in copper neurotoxicity. WT cortical, cerebellar, and hippocampal neurons were significantly more susceptible than their respective APP(-/-) neurons to toxicity induced by physiological concentrations of copper but not by zinc or iron. There was no difference in copper toxicity between APLP2(-/-) and WT neurons, demonstrating specificity for APP-associated copper toxicity. Copper uptake was the same in WT and APP(-/-) neurons, suggesting APP may interact with copper to induce a localized increase in oxidative stress through copper (I) production. This was supported by significantly higher levels of copper-induced lipid peroxidation in WT neurons. Treatment of neuronal cultures with a peptide corresponding to the human APP copper-binding domain (APP142-166) potentiated copper but not iron or zinc toxicity. Incubation of APP142-166 with low-density lipoprotein (LDL) and copper resulted in significantly increased lipid peroxidation compared to copper and LDL alone. Substitution of the copper coordinating histidine residues with asparagines (APP142-166(H147N, H149N, H151N)) abrogated the toxic effects. A peptide corresponding to the zinc-binding domain (APP181-208) failed to induce copper or zinc toxicity in neuronal cultures. These data support a role for the APP copper-binding domain in APP-mediated copper (I) generation and toxicity in primary neurons, a process that has important implications for Alzheimer's disease and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531420      PMCID: PMC6782934     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

Authors:  D R Brown; W J Schulz-Schaeffer; B Schmidt; H A Kretzschmar
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

3.  The amyloid beta protein precursor or proteinase nexin II from mouse is closer related to its human homolog than previously reported.

Authors:  B De Strooper; F Van Leuven; H Van den Berghe
Journal:  Biochim Biophys Acta       Date:  1991-12-02

4.  Prion protein fragment interacts with PrP-deficient cells.

Authors:  D R Brown; B Schmidt; H A Kretzschmar
Journal:  J Neurosci Res       Date:  1998-05-01       Impact factor: 4.164

5.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

6.  Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis.

Authors:  K J Ivins; E T Bui; C W Cotman
Journal:  Neurobiol Dis       Date:  1998-11       Impact factor: 5.996

7.  Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  P K Andrus; T J Fleck; M E Gurney; E D Hall
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

8.  Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).

Authors:  H H Slunt; G Thinakaran; C Von Koch; A C Lo; R E Tanzi; S S Sisodia
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

9.  Neurotoxicity of a prion protein fragment.

Authors:  G Forloni; N Angeretti; R Chiesa; E Monzani; M Salmona; O Bugiani; F Tagliavini
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

Review 10.  Genetic and molecular basis for copper toxicity.

Authors:  Z L Harris; J D Gitlin
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

View more
  59 in total

1.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 2.  Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Neurol       Date:  2010-05-05       Impact factor: 5.330

Review 3.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 4.  [The role of copper in the pathophysiology of Alzheimer's disease].

Authors:  H Kessler; F-G Pajonk; T Supprian; P Falkai; G Multhaup; T A Bayer
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

5.  Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo.

Authors:  Tamara Jefferson; Mirsada Čaušević; Ulrich auf dem Keller; Oliver Schilling; Simone Isbert; Rebecca Geyer; Wladislaw Maier; Sabrina Tschickardt; Thorsten Jumpertz; Sascha Weggen; Judith S Bond; Christopher M Overall; Claus U Pietrzik; Christoph Becker-Pauly
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

6.  The involvement of copper transporter in lead-induced oxidative stress in astroglia.

Authors:  Yongchang Qian; Ying Zheng; Kenneth S Ramos; Evelyn Tiffany-Castiglioni
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

7.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.

Authors:  Jochen Herms; Brigitte Anliker; Sabine Heber; Sabine Ring; Martin Fuhrmann; Hans Kretzschmar; Sangram Sisodia; Ulrike Müller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

8.  Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD.

Authors:  Masashi Kitazawa; David Cheng; Frank M Laferla
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

Review 9.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

10.  Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Gloria Dal Forno; Piero Antuono; David R Wekstein; Concetta R Capo; Carlo Salustri; Paolo M Rossini
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.